08:26 IST
NSE
Business UpdateBiocon Ltd BIOCON
Biocon Business Update
Biocon signed a licence agreement with Janssen to commercialise biosimilar Yesintek in nine more markets, including Australia, Brazil and China. No deal value is disclosed.